The Pricing Evolution of Personalized Medicines

Grant D. Lawless, RPh, MD, FACP

Video Categories: Pricing

Grant Lawless discusses the changing landscape of pricing personalized medicines
March 31, 2015

Combining Novel Agents for CLL

Dr. Jennifer R. Brown talks about combining novel agents for treating CLL as the next step to achieve longer remissions for patients. Until now, novel agents have only been used individually or in combination with antibodies. New studies are being designed to measure the efficacy of combining novel agents with [ Read More ]

January 30, 2014

Communicating Value of Personalized Medicine to All Stakeholders in Healthcare

Listen as Dr Argawala articulates the value proposition of personalized medicine for all stakeholders in healthcare.